Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

EditForce, a Japan-based creator of DNA and RNA drug development technology, raised $4.5m in funding yesterday from structural wood members manufacturer Yoshimei, MP Healthcare Venture Management and FFG Venture Investment. The commitment is an extension to the $7.3m round led by Newton Biocapital in May 2021, when University of Tokyo Edge Capital (UTEC), Itochu Technology Ventures, a subsidiary of trading group Itochu, telecoms firm KDDI and Global Brain also invested. UTEC and Itochu Technology Ventures contributed to an $7.8m…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).